Scott Haden Kollins
Adjunct Professor in the Department of Psychiatry and Behavioral Sciences
Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals. Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA. He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.
Current Appointments & Affiliations
- Adjunct Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry, Child & Family Mental Health & Community Psychiatry, Psychiatry & Behavioral Sciences 2021
- Membership in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2015
Contact Information
- 2608 Erwin Road Lakeview Pavi, Durham, NC 27705
- Box 3527 Med Ctr, Durham, NC 27710
-
kolli001@mc.duke.edu
(919) 681-0014
- Background
-
Education, Training, & Certifications
- Ph.D., Auburn University 1997
-
Previous Appointments & Affiliations
- Faculty Network Member of the Duke Institute for Brain Sciences, Duke Institute for Brain Sciences, University Institutes and Centers 2009 - 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2013 - 2021
- Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2013 - 2021
- Professor of Psychology and Neuroscience, Psychology & Neuroscience, Trinity College of Arts & Sciences 2013 - 2021
- Affiliate of the Center for Child and Family Policy, Center for Child and Family Policy, Sanford School of Public Policy 2015 - 2021
- Vice-Chair, Research Strategy and Development in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2012 - 2018
- Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2008 - 2012
- Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2007 - 2008
- Assistant Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2002 - 2006
- Assistant Clinical Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2000 - 2002
- Recognition
-
In the News
-
DEC 9, 2019 School of Medicine -
DEC 19, 2018 Duke Health News -
DEC 7, 2017 Duke Health News -
SEP 7, 2017 Duke Health News -
MAY 13, 2014 Duke Today -
MAY 12, 2014 USA Today
-
- Research
-
Selected Grants
- Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness awarded by National Institutes of Health 2022 - 2027
- Duke Center for ADHD in Girls/Women awarded by Gratis Foundation 2021 - 2025
- Duke Women's Reproductive Health Research Scholars awarded by National Institutes of Health 2020 - 2025
- Scalable Computational Platform For Active Closed-Loop Behavioral Coding in Autism Spectrum Disorder awarded by National Institutes of Health 2019 - 2024
- Unified Program for Therapeutics in Children awarded by National Institutes of Health 2019 - 2024
- Duke CTSA (TL1) Year 5 awarded by National Institutes of Health 2018 - 2024
- Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHD awarded by National Institutes of Health 2016 - 2022
- Paternal Transgenerational Epigenetic Legacy from Use of Cannabis awarded by John Templeton Foundation 2017 - 2022
- Maternal obesity, child executive functions and child weight gain awarded by National Institutes of Health 2015 - 2022
- Targeting reward dysfunction as a mechanism to improve smoking cessation awarded by National Institutes of Health 2016 - 2022
- Mobile health interventions for varenicline adherence among HIV-positive smokers awarded by National Institutes of Health 2017 - 2021
- Increasing Motivation in ADHD Via Self-activation of VTA awarded by National Institutes of Health 2016 - 2021
- Smoking/Nicotine Dependence in Attention Deficit Hyperactivity Disorder (ADHD) awarded by National Institutes of Health 2017 - 2020
- Modeling the Neurobehavioral Basis of Extrinsic and Volitional Motivation in ADHD awarded by National Institutes of Health 2017 - 2020
- Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers awarded by National Institutes of Health 2016 - 2020
- A randomized, sham-controlled, crossover study to evaluate the effects of noise cancelling headphones on neurocognitive and academic outcomes in children and adolescents diagnosed with ADHD awarded by Bose Corporation 2017 - 2019
- Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers awarded by National Institutes of Health 2015 - 2019
- A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Parallel Laboratory Classroom Study with KP415 in Children with Attention-Deficit/Hyperactivity Disorder awarded by KemPharm, Inc 2017 - 2019
- A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years Diagnosed with Attention-deficit/Hyperactivity Disorder awarded by Shire Pharmaceutical Development US Inc. 2015 - 2019
- mSMART: Mobile App based Personalized Solutions and Tools for Medication Adherence of Rx Pills awarded by Intelligent Automation Inc. 2014 - 2019
- Protecting Neurodevelopment in Latino Migrant Children by Reduced Exposure to Organophosphate Pesticides awarded by National Institutes of Health 2017 - 2019
- RP-BP-EF004: A 12-Month Open Label Safety Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Children Ages 4-5 Years Diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) awarded by Rhodes Pharmaceuticals L.P. 2016 - 2018
- Behavioral and genetic mechanisms of smoking risk in individuals with ADHD awarded by National Institutes of Health 2012 - 2018
- Smoking Abstinence in ADHD and non-ADHD Smokers: Assessing the Role of Emotion Dysregulation awarded by National Institutes of Health 2012 - 2018
- A Pharmacokinetic Study of Aptensio XR¿ (Methylphenidate Hydrochloride) Extended-Release capsules in Male or Female Pre-School Children 4 to Under 6 years of age with ADHD in Fed Condition awarded by Rhodes Pharmaceuticals L.P. 2015 - 2018
- RP-BP-EF003: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR®) in Children Ages 4 to Under 6 Years Diagnosed with ADHD awarded by Rhodes Pharmaceuticals L.P. 2016 - 2018
- Characterizing ADHD using a behavioral model of dopamine function awarded by Brain and Behavior Research Foundation 2016 - 2018
- Pilot Project: Effects of Cannabis on the Epigenome of Humans and Rats awarded by John Templeton Foundation 2016 - 2017
- A Phase 2, Open-label, Multicenter, Exploratory Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children Aged 4-5 Years with Attention Deficit/Hyperactivity Disorder awarded by Shire Pharmaceutical Development US Inc. 2015 - 2017
- mGluR Mutations in ADHD awarded by Medgenics, Inc 2016 - 2017
- A 6-week, Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline versus Placebo in Subjects 6 to 12 Years of Age with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2017
- A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2017
- A Ph. 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety & Efficacy of Evening-dosed HLD200, a Novel Delayed & ER Formulation (DELEXIS) of Methylphenidate Hydrochloride, on Post waking, Early Mor awarded by Ironshore Pharmaceuticals & Development, Inc 2015 - 2016
- An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2015 - 2016
- SEP-225289 in Adults with Attention Deficit Hyperactivity Disorder (ADHD) awarded by Sunovion Pharmaceuticals, Inc 2014 - 2016
- A Phase IIb, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Crossover, Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults with Attention-Deficit Hyperactivity Disorder (ADHD) awarded by Neurovance 2015 - 2016
- A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) with ADHD in a Laboratory Classroom awarded by Arbor Pharmaceuticals, Inc 2013 - 2015
- A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age with Attention Deficit Hyperactivity Disorder awarded by Sunovion Pharmaceuticals, Inc 2015
- A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-ARM, MULTI-CENTER STUDY MEASURING THE EFFICACY AND SAFETY OF PRC-063 IN ADOLESCENT ADHD PATIENTS awarded by Purdue Pharma L.P. 2014 - 2015
- A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-ARM, MULTI-CENTER STUDY MEASURING THE EFFICACY AND SAFETY OF PRC-063 IN ADULT ADHD PATIENTS awarded by Purdue Pharma L.P. 2014 - 2015
- A SIX-MONTH, OPEN-LABEL, MULTI-CENTER STUDY OF THE SAFETY AND EFFICACY OF PRC-063 IN ADULTS AND ADOLESCENTS WITH ADHD awarded by Purdue Pharma L.P. 2014 - 2015
- A Phase III Clinical Endpoint Evaluation Study Examining the Safety and Efficacy of HLD200 in Pediatric Subjects with Attention-Deficit Hyperactivity Disorder (CEES ADHD) awarded by Ironshore Pharmaceuticals & Development, Inc 2014 - 2015
- A 6-week Randomized, Multicenter, Double-blind, Parallel, Fixed-dose Study of MG01CI (Metadoxine Immediate-release/Slow-release, Bilayer Caplet) 1400 mg Compared with Placebo in Adults with Attention Deficit/Hyperactivity Disorder (ADHD) awarded by Alcobra Ltd. 2014 - 2015
- Amphetamine Extended-Release Oral Suspension in the Treatment of Children with ADHD: A Laboratory School Study awarded by Tris Pharma, Inc. 2014 - 2015
- Project 1: Evaluating New Nicotine Standards in Cigarettes - Supplement awarded by University of Pittsburgh 2013 - 2014
- Elucidating links between ADHD symptoms and tobacco/alcohol use trajectories awarded by National Institutes of Health 2010 - 2014
- Neuropharmacology of Response Inhibition in Comorbid ADHD and Nicotine Dependence awarded by National Institutes of Health 2009 - 2014
- A randomized, multicenter, double-blind, placebo-controlled, parallel group study of NT0102 Methylphenidate Polistirex Extended-Release Oral Disintegrating Tablets in children w/ADHD awarded by Neos Therapeutics, Inc 2013 - 2014
- Sensitivity to smoking reinforcement in women: menstrual cycle effects awarded by National Institutes of Health 2011 - 2013
- Ecological Momentary Assessment of Ad Lib Smoking in ADHD Smokers awarded by National Institutes of Health 2011 - 2012
- Genetic basis of smoking abstinence, smoking reinforcement, and inhibitory control awarded by National Institutes of Health 2009 - 2012
- Smoking reinforcement in adults with and without ADHD awarded by National Institutes of Health 2009 - 2012
- Follow up of the PATS sample awarded by National Institutes of Health 2004 - 2010
- Candidate Gene Analysis of Persistent AD/HD awarded by National Institutes of Health 2004 - 2010
- Mechanisms of Nicotine Dependence in ADHD Adults awarded by National Institutes of Health 2007 - 2009
- Development of Behavorial Screening Tools for ADHD awarded by Environmental Protection Agency 2005 - 2008
- Methylphenidate Abuse Potential in ADHD Adults awarded by National Institutes of Health 2005 - 2008
- Functional Neuroanatomical Deficits in ADHD Families awarded by National Institutes of Health 2002 - 2006
- Attention Deficit Hyperactivity Disorder awarded by Environmental Protection Agency 2003 - 2004
-
External Relationships
- Adlon Pharma
- Akili Interactive
- Behavioral Innovations Group
- Corium
- Holmusk
- Lumos Labs
- Otsuka Pharmaceuticals
- Sunovion Pharmaceuticals Inc.
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Fuemmeler, Bernard F., Trevin E. Glasgow, Julia C. Schechter, Rachel Maguire, Yaou Sheng, Tatyana Bidopia, D Jeremy Barsell, et al. “Prenatal and Childhood Smoke Exposure Associations with Cognition, Language, and Attention-Deficit/Hyperactivity Disorder.” J Pediatr 256 (May 2023): 77-84.e1. https://doi.org/10.1016/j.jpeds.2022.11.041.Full Text Link to Item
-
Taquet, Maxime, Kira Griffiths, Emily O. C. Palmer, Sheryl Ker, Christian Liman, Soon Nan Wee, Scott H. Kollins, and Rashmi Patel. “Early trajectory of clinical global impression as a transdiagnostic predictor of psychiatric hospitalisation: a retrospective cohort study.” Lancet Psychiatry 10, no. 5 (May 2023): 334–41. https://doi.org/10.1016/S2215-0366(23)00066-4.Full Text Link to Item
-
Vosburg, Suzanne K., Stephen V. Faraone, Elizabeth Riley, Timothy Whitaker, Jessica Kardish, David Baker, Scott H. Kollins, and Craig R. Rush. “Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30: Results From A Crowdsourcing Platform.” J Atten Disord 27, no. 1 (January 2023): 14–25. https://doi.org/10.1177/10870547221112948.Full Text Link to Item
-
Carpenter, Kimberly L. H., Naomi O. Davis, Marina Spanos, Maura Sabatos-DeVito, Rachel Aiello, Grace T. Baranek, Scott N. Compton, et al. “Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms.” J Autism Dev Disord, October 12, 2022. https://doi.org/10.1007/s10803-022-05753-2.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Ke Will Wang, Scott H. Kollins, Richard J. Chung, Casey Keller, and Matthew M. Engelhard. “Regularity and Timing of Sleep Patterns and Behavioral Health Among Adolescents.” J Dev Behav Pediatr 43, no. 4 (May 1, 2022): 188–96. https://doi.org/10.1097/DBP.0000000000001013.Full Text Link to Item
-
Patel, Rashmi, Soon Nan Wee, Rajagopalan Ramaswamy, Simran Thadani, Jesisca Tandi, Ruchir Garg, Nathan Calvanese, et al. “NeuroBlu, an electronic health record (EHR) trusted research environment (TRE) to support mental healthcare analytics with real-world data.” Bmj Open 12, no. 4 (April 22, 2022): e057227. https://doi.org/10.1136/bmjopen-2021-057227.Full Text Link to Item
-
Breslav, Alexander D. S., Nancy L. Zucker, Julia C. Schechter, Alesha Majors, Tatyana Bidopia, Bernard F. Fuemmeler, Scott H. Kollins, and Scott A. Huettel. “Shuffle the Decks: Children Are Sensitive to Incidental Nonrandom Structure in a Sequential-Choice Task.” Psychol Sci 33, no. 4 (April 2022): 550–62. https://doi.org/10.1177/09567976211042007.Full Text Link to Item
-
White, Michelle J., Julia C. Schechter, Benjamin Neely, Camila Reyes, Rachel L. Maguire, Eliana M. Perrin, Albert J. Ksinan, Scott H. Kollins, and Bernard F. Fuemmeler. “Parenting Stress, Child Weight-Related Behaviors, and Child Weight Status.” Child Obes 18, no. 3 (April 2022): 150–59. https://doi.org/10.1089/chi.2021.0098.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Scott H. Kollins, Sujay Kansagra, Ke Will Wang, and Matthew M. Engelhard. “Impact of daily caffeine intake and timing on electroencephalogram-measured sleep in adolescents.” J Clin Sleep Med 18, no. 3 (March 1, 2022): 877–84. https://doi.org/10.5664/jcsm.9736.Full Text Link to Item
-
Kollins, Scott H. “Editorial: The gathering storm: a US perspective on the scientific response to the COVID-19 child and adolescent mental health crisis.” J Child Psychol Psychiatry 63, no. 2 (February 2022): 129–31. https://doi.org/10.1111/jcpp.13576.Full Text Link to Item
-
Dew, Rachel E., Scott H. Kollins, and Harold G. Koenig. “ADHD, Religiosity, and Psychiatric Comorbidity in Adolescence and Adulthood.” J Atten Disord 26, no. 2 (January 2022): 307–18. https://doi.org/10.1177/1087054720972803.Full Text Link to Item
-
Franz, Lauren, Jill Howard, Marisa Viljoen, Linmarie Sikich, Tara Chandrasekhar, Scott H. Kollins, Lawrence Lee, et al. “Pragmatic adaptations of telehealth-delivered caregiver coaching for children with autism in the context of COVID-19: Perspectives from the United States and South Africa.” Autism 26, no. 1 (January 2022): 270–75. https://doi.org/10.1177/13623613211022585.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Matthew M. Engelhard, Ann Marie Navar, and Scott H. Kollins. “Author Correction: Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.” Sci Rep 11, no. 1 (December 16, 2021): 24398. https://doi.org/10.1038/s41598-021-03253-4.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Maggie M. Sweitzer, Scott H. Kollins, and John T. Mitchell. “Eveningness Diurnal Preference: Putting the "Sluggish" in Sluggish Cognitive Tempo.” J Atten Disord 25, no. 14 (December 2021): 2060–67. https://doi.org/10.1177/1087054720959697.Full Text Link to Item
-
García-Marín, Luis M., Adrián I. Campos, Gabriel Cuéllar-Partida, Sarah E. Medland, Scott H. Kollins, and Miguel E. Rentería. “Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD.” Sci Rep 11, no. 1 (November 19, 2021): 22628. https://doi.org/10.1038/s41598-021-01517-7.Full Text Link to Item
-
Kollins, Scott H., Rene Braeckman, Sven Guenther, Andrew C. Barrett, Travis C. Mickle, Charles Oh, Andrea Marraffino, Andrew J. Cutler, and Matthew N. Brams. “A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol 31, no. 9 (November 2021): 597–609. https://doi.org/10.1089/cap.2021.0077.Full Text Link to Item
-
Weiss, Margaret D., Andrew J. Cutler, Scott H. Kollins, and Graeme A. E. Donnelly. “Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension.” J Child Adolesc Psychopharmacol 31, no. 9 (November 2021): 610–22. https://doi.org/10.1089/cap.2021.0034.Full Text Link to Item
-
Engelhard, Matthew, Samuel Berchuck, Jyotsna Garg, Shelley Rusincovitch, Geraldine Dawson, and Scott Kollins. “Patterns of Health Services Use Before Age 1 in Children Later Diagnosed With ADHD.” J Atten Disord 25, no. 12 (October 2021): 1639. https://doi.org/10.1177/1087054720914352.Full Text Link to Item
-
Weissler, E Hope, Tristan Naumann, Tomas Andersson, Rajesh Ranganath, Olivier Elemento, Yuan Luo, Daniel F. Freitag, et al. “Correction to: The role of machine learning in clinical research: transforming the future of evidence generation.” Trials 22, no. 1 (September 6, 2021): 593. https://doi.org/10.1186/s13063-021-05571-4.Full Text Link to Item
-
Faraone, Stephen V., Tobias Banaschewski, David Coghill, Yi Zheng, Joseph Biederman, Mark A. Bellgrove, Jeffrey H. Newcorn, et al. “The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.” Neurosci Biobehav Rev 128 (September 2021): 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022.Full Text Link to Item
-
Perochon, Sam, Matias Di Martino, Rachel Aiello, Jeffrey Baker, Kimberly Carpenter, Zhuoqing Chang, Scott Compton, et al. “A scalable computational approach to assessing response to name in toddlers with autism.” J Child Psychol Psychiatry 62, no. 9 (September 2021): 1120–31. https://doi.org/10.1111/jcpp.13381.Full Text Link to Item
-
Sweitzer, Maggie M., Lauren R. Pacek, Rachel V. Kozink, Erin Locey, Scott H. Kollins, Eric C. Donny, and F Joseph McClernon. “Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.” Psychopharmacology (Berl) 238, no. 9 (September 2021): 2429–38. https://doi.org/10.1007/s00213-021-05864-1.Full Text Link to Item
-
Weissler, E Hope, Tristan Naumann, Tomas Andersson, Rajesh Ranganath, Olivier Elemento, Yuan Luo, Daniel F. Freitag, et al. “The role of machine learning in clinical research: transforming the future of evidence generation.” Trials 22, no. 1 (August 16, 2021): 537. https://doi.org/10.1186/s13063-021-05489-x.Full Text Link to Item
-
Chang, Zhuoqing, J Matias Di Martino, Rachel Aiello, Jeffrey Baker, Kimberly Carpenter, Scott Compton, Naomi Davis, et al. “Computational Methods to Measure Patterns of Gaze in Toddlers With Autism Spectrum Disorder.” Jama Pediatr 175, no. 8 (August 1, 2021): 827–36. https://doi.org/10.1001/jamapediatrics.2021.0530.Full Text Link to Item
-
Maguire, Rachel L., John S. House, Dillon T. Lloyd, Harlyn G. Skinner, Terrence K. Allen, Asifa Mohamed Raffi, David A. Skaar, et al. “Associations between maternal obesity, gestational cytokine levels and child obesity in the NEST cohort.” Pediatr Obes 16, no. 7 (July 2021): e12763. https://doi.org/10.1111/ijpo.12763.Full Text Link to Item
-
Ksinan, Albert J., Yaou Sheng, Elizabeth K. Do, Julia C. Schechter, Junfeng Jim Zhang, Rachel L. Maguire, Cathrine Hoyo, et al. “Identifying the Best Questions for Rapid Screening of Secondhand Smoke Exposure Among Children.” Nicotine Tob Res 23, no. 7 (June 8, 2021): 1217–23. https://doi.org/10.1093/ntr/ntaa254.Full Text Link to Item
-
Childress, Ann C., Scott H. Kollins, Andrew J. Cutler, Andrea Marraffino, and Carolyn R. Sikes. “Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol 31, no. 5 (June 2021): 342–49. https://doi.org/10.1089/cap.2020.0142.Full Text Link to Item
-
Fallavollita, Westley L., Elizabeth K. Do, Julia C. Schechter, Scott H. Kollins, Junfeng Jim Zheng, Jian Qin, Rachel L. Maguire, Cathrine Hoyo, Susan K. Murphy, and Bernard F. Fuemmeler. “Smoke-Free Home Rules and Association with Child Secondhand Smoke Exposure among Mother-Child Dyad Relationships.” Int J Environ Res Public Health 18, no. 10 (May 14, 2021). https://doi.org/10.3390/ijerph18105256.Full Text Link to Item
-
Fuemmeler, Bernard F., Mikhail G. Dozmorov, Elizabeth K. Do, Junfeng Jim Zhang, Carole Grenier, Zhiqing Huang, Rachel L. Maguire, Scott H. Kollins, Cathrine Hoyo, and Susan K. Murphy. “DNA Methylation in Babies Born to Nonsmoking Mothers Exposed to Secondhand Smoke during Pregnancy: An Epigenome-Wide Association Study.” Environ Health Perspect 129, no. 5 (May 2021): 57010. https://doi.org/10.1289/EHP8099.Full Text Open Access Copy Link to Item
-
Young, Jonathan R., Adare Yanagihara, Rachel Dew, and Scott H. Kollins. “Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions.” Cns Drugs 35, no. 4 (April 2021): 403–24. https://doi.org/10.1007/s40263-021-00806-z.Full Text Link to Item
-
Kollins, Scott H., Ann Childress, Andrew C. Heusser, and Jacqueline Lutz. “Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD.” Npj Digit Med 4, no. 1 (March 26, 2021): 58. https://doi.org/10.1038/s41746-021-00429-0.Full Text Link to Item
-
Addicott, Merideth A., John M. Pearson, Julia C. Schechter, Jeffrey J. Sapyta, Margaret D. Weiss, and Scott H. Kollins. “Attention-deficit/hyperactivity disorder and the explore/exploit trade-off.” Neuropsychopharmacology 46, no. 3 (February 2021): 614–21. https://doi.org/10.1038/s41386-020-00881-8.Full Text Link to Item
-
Kollins, Scott H. “Editorial: Is child mental health research structurally racist?” J Child Psychol Psychiatry 62, no. 2 (February 2021): 111–13. https://doi.org/10.1111/jcpp.13376.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Scott H. Kollins, and John T. Mitchell. “Sluggish Cognitive Tempo in Adults Referred for an ADHD Evaluation: A Psychometric Analysis of Self- and Collateral Report.” J Atten Disord 25, no. 3 (February 2021): 322–31. https://doi.org/10.1177/1087054718787894.Full Text Link to Item
-
Friis-Healy, Elsa A., Gabriela A. Nagy, and Scott H. Kollins. “It Is Time to REACT: Opportunities for Digital Mental Health Apps to Reduce Mental Health Disparities in Racially and Ethnically Minoritized Groups.” Jmir Ment Health 8, no. 1 (January 26, 2021): e25456. https://doi.org/10.2196/25456.Full Text Link to Item
-
Schrott, Rose, Susan K. Murphy, Jennifer L. Modliszewski, Dillon E. King, Bendu Hill, Nilda Itchon-Ramos, Douglas Raburn, et al. “Refraining from use diminishes cannabis-associated epigenetic changes in human sperm.” Environ Epigenet 7, no. 1 (2021): dvab009. https://doi.org/10.1093/eep/dvab009.Full Text Link to Item
-
Mitchell, John T., Naomi Ornstein Davis, Scott H. Kollins, and Jessica R. Lunsford-Avery. “Sluggish cognitive tempo (SCT) in an adult outpatient sample seeking an attention-deficit/hyperactivity disorder assessment: Age of onset and assessment method impact on SCT rates.” J Psychiatr Res 131 (December 2020): 203–8. https://doi.org/10.1016/j.jpsychires.2020.09.013.Full Text Link to Item
-
Friis-Healy, Elsa A., Gabriela A. Nagy, and Scott H. Kollins. “It Is Time to REACT: Opportunities for Digital Mental Health Apps to Reduce Mental Health Disparities in Racially and Ethnically Minoritized Groups (Preprint),” November 2, 2020. https://doi.org/10.2196/preprints.25456.Full Text
-
Engelhard, Matthew M., Samuel I. Berchuck, Jyotsna Garg, Ricardo Henao, Andrew Olson, Shelley Rusincovitch, Geraldine Dawson, and Scott H. Kollins. “Health system utilization before age 1 among children later diagnosed with autism or ADHD.” Sci Rep 10, no. 1 (October 19, 2020): 17677. https://doi.org/10.1038/s41598-020-74458-2.Full Text Link to Item
-
Adjei, Akwete L., Inder Chaudhary, Scott H. Kollins, and Americo Padilla. “A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder.” Paediatr Drugs 22, no. 5 (October 2020): 561–70. https://doi.org/10.1007/s40272-020-00409-z.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Casey Keller, Scott H. Kollins, Andrew D. Krystal, Leah Jackson, and Matthew M. Engelhard. “Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study.” Jmir Mhealth Uhealth 8, no. 10 (October 1, 2020): e20590. https://doi.org/10.2196/20590.Full Text Link to Item
-
Fuemmeler, Bernard F., Yaou Sheng, Julia C. Schechter, Elizabeth Do, Nancy Zucker, Alesha Majors, Rachel Maguire, Susan K. Murphy, Cathrine Hoyo, and Scott H. Kollins. “Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood.” Pediatr Obes 15, no. 7 (July 2020): e12631. https://doi.org/10.1111/ijpo.12631.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Casey Keller, Scott H. Kollins, Andrew D. Krystal, Leah Jackson, and Matthew M. Engelhard. “Feasibility and Acceptability of Wearable Sleep Electroencephalogram Device Use in Adolescents: Observational Study (Preprint),” May 25, 2020. https://doi.org/10.2196/preprints.20590.Full Text
-
Childress, Ann C., Robert L. Findling, James Wu, Scott H. Kollins, Yi Wang, Patrick Martin, and Brigitte Robertson. “Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol 30, no. 3 (April 2020): 128–36. https://doi.org/10.1089/cap.2019.0117.Full Text Link to Item
-
Kollins, Scott H., Denton J. DeLoss, Elena Cañadas, Jacqueline Lutz, Robert L. Findling, Richard S. E. Keefe, Jeffery N. Epstein, Andrew J. Cutler, and Stephen V. Faraone. “A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial.” Lancet Digit Health 2, no. 4 (April 2020): e168–78. https://doi.org/10.1016/S2589-7500(20)30017-0.Full Text Link to Item
-
Kollins, Scott H., Maggie M. Sweitzer, F Joseph McClernon, and Kenneth A. Perkins. “Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use.” Neuropsychopharmacology 45, no. 5 (April 2020): 851–56. https://doi.org/10.1038/s41386-019-0581-7.Full Text Link to Item
-
Childress, Ann C., Scott H. Kollins, Henry C. Foehl, Jeffrey H. Newcorn, Greg Mattingly, Robert J. Kupper, and Akwete L. Adjei. “Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.” J Child Adolesc Psychopharmacol 30, no. 2 (March 2020): 58–68. https://doi.org/10.1089/cap.2019.0085.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Matthew M. Engelhard, Ann Marie Navar, and Scott H. Kollins. “Author Correction: Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.” Sci Rep 10, no. 1 (February 14, 2020): 2993. https://doi.org/10.1038/s41598-020-59762-1.Full Text Link to Item
-
Kollins, Scott H. “Editorial: From risk prediction to action: leveraging electronic health records to improve pediatric population mental health.” J Child Psychol Psychiatry 61, no. 2 (February 2020): 113–15. https://doi.org/10.1111/jcpp.13199.Full Text Link to Item
-
Schechter, Julia, Elizabeth K. Do, Junfeng Jim Zhang, Cathrine Hoyo, Susan K. Murphy, Scott H. Kollins, and Bernard Fuemmeler. “Effect of Prenatal Smoke Exposure on Birth Weight: The Moderating Role of Maternal Depressive Symptoms.” Nicotine Tob Res 22, no. 1 (January 27, 2020): 40–47. https://doi.org/10.1093/ntr/nty267.Full Text Open Access Copy Link to Item
-
Lunsford-Avery, Jessica R., Katherine S. F. Damme, Matthew M. Engelhard, Scott H. Kollins, and Vijay A. Mittal. “Sleep/Wake Regularity Associated with Default Mode Network Structure among Healthy Adolescents and Young Adults.” Sci Rep 10, no. 1 (January 16, 2020): 509. https://doi.org/10.1038/s41598-019-57024-3.Full Text Link to Item
-
Schrott, Rose, Kelly Acharya, Nilda Itchon-Ramos, Andrew B. Hawkey, Erica Pippen, John T. Mitchell, Scott H. Kollins, Edward D. Levin, and Susan K. Murphy. “Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm.” Epigenetics 15, no. 1–2 (2020): 161–73. https://doi.org/10.1080/15592294.2019.1656158.Full Text Link to Item
-
Mitchell, John T., F Joseph McClernon, Jean C. Beckham, Richard A. Brown, Carl W. Lejuez, and Scott H. Kollins. “Smoking abstinence effects on emotion dysregulation in adult cigarette smokers with and without attention-deficit/hyperactivity disorder.” Drug Alcohol Depend 205 (December 1, 2019): 107594. https://doi.org/10.1016/j.drugalcdep.2019.107594.Full Text Link to Item
-
Xue, Hong, Rachel L. Maguire, Jin Liu, Scott H. Kollins, Susan K. Murphy, Cathrine Hoyo, and Bernard F. Fuemmeler. “Snacking frequency and dietary intake in toddlers and preschool children.” Appetite 142 (November 1, 2019): 104369. https://doi.org/10.1016/j.appet.2019.104369.Full Text Link to Item
-
“Corrigendum: Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.” Nicotine Tob Res 21, no. 10 (September 19, 2019): 1449. https://doi.org/10.1093/ntr/nty260.Full Text Link to Item
-
Engelhard, Matthew M., and Scott H. Kollins. “The Many Channels of Screen Media Technology in ADHD: a Paradigm for Quantifying Distinct Risks and Potential Benefits.” Curr Psychiatry Rep 21, no. 9 (August 13, 2019): 90. https://doi.org/10.1007/s11920-019-1077-1.Full Text Link to Item
-
Addicott, Merideth A., Julia C. Schechter, Jeffrey J. Sapyta, James P. Selig, Scott H. Kollins, and Margaret D. Weiss. “Methylphenidate increases willingness to perform effort in adults with ADHD.” Pharmacol Biochem Behav 183 (August 2019): 14–21. https://doi.org/10.1016/j.pbb.2019.06.008.Full Text Link to Item
-
Raman, Sudha, Matthew Engelhard, and Scott H. Kollins. “Driving the Point Home: Novel Approaches to Mitigate Crash Risk for Patients With ADHD.” Pediatrics, May 20, 2019. https://doi.org/10.1542/peds.2019-0820.Full Text Link to Item
-
Mitchell, John T., Andrea L. Howard, Katherine A. Belendiuk, Traci M. Kennedy, Annamarie Stehli, James M. Swanson, Lily Hechtman, et al. “Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.” Nicotine Tob Res 21, no. 5 (April 17, 2019): 638–47. https://doi.org/10.1093/ntr/nty045.Full Text Link to Item
-
Barry, Caroline M., Aditi Sabhlok, Victoria C. Saba, Alesha D. Majors, Julia C. Schechter, Erica L. Levine, Martin Streicher, Gary G. Bennett, Scott H. Kollins, and Bernard F. Fuemmeler. “An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis.” Jmir Public Health Surveill 5, no. 2 (April 2, 2019): e11666. https://doi.org/10.2196/11666.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Scott H. Kollins, and Vijay A. Mittal. “Eveningness diurnal preference associated with poorer socioemotional cognition and social functioning among healthy adolescents and young adults.” Chronobiol Int 36, no. 3 (March 2019): 439–44. https://doi.org/10.1080/07420528.2018.1538156.Full Text Link to Item
-
Fuemmeler, Bernard F., Nancy Zucker, Yaou Sheng, Carmen E. Sanchez, Rachel Maguire, Susan K. Murphy, Scott H. Kollins, and Cathrine Hoyo. “Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children.” Int J Environ Res Public Health 16, no. 4 (February 25, 2019). https://doi.org/10.3390/ijerph16040667.Full Text Open Access Copy Link to Item
-
Do, E. K., N. L. Zucker, Z. Y. Huang, J. C. Schechter, S. H. Kollins, R. L. Maguire, S. K. Murphy, C. Hoyo, and B. F. Fuemmeler. “Associations between imprinted gene differentially methylated regions, appetitive traits and body mass index in children.” Pediatr Obes 14, no. 2 (February 2019): e12454. https://doi.org/10.1111/ijpo.12454.Full Text Link to Item
-
Lunsford-Avery, Jessica R., and Scott H. Kollins. “Editorial Perspective: Delayed circadian rhythm phase: a cause of late-onset attention-deficit/hyperactivity disorder among adolescents?” J Child Psychol Psychiatry 59, no. 12 (December 2018): 1248–51. https://doi.org/10.1111/jcpp.12956.Full Text Link to Item
-
Kollins, Scott H. “Moving Beyond Symptom Remission to Optimize Long-term Treatment of Attention-Deficit/Hyperactivity Disorder.” Jama Pediatr 172, no. 10 (October 1, 2018): 901–2. https://doi.org/10.1001/jamapediatrics.2018.1642.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Matthew M. Engelhard, Ann Marie Navar, and Scott H. Kollins. “Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.” Sci Rep 8, no. 1 (September 21, 2018): 14158. https://doi.org/10.1038/s41598-018-32402-5.Full Text Open Access Copy Link to Item
-
Faraone, Stephen V., Ann Childress, Sharon B. Wigal, Scott H. Kollins, Mary Ann McDonnell, Norberto J. DeSousa, and F Randy Sallee. “Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.” J Atten Disord 22, no. 11 (September 2018): 1066–73. https://doi.org/10.1177/1087054715619009.Full Text Link to Item
-
Barry, Caroline M., Aditi Sabhlok, Victoria C. Saba, Alesha D. Majors, Julia C. Schechter, Erica L. Levine, Martin Streicher, Gary G. Bennett, Scott H. Kollins, and Bernard F. Fuemmeler. “An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis (Preprint),” July 23, 2018. https://doi.org/10.2196/preprints.11666.Full Text
-
Gao, Lu, Xiaochen Liu, Joshua Millstein, Kimberly D. Siegmund, Louis Dubeau, Rachel L. Maguire, Junfeng Jim Zhang, et al. “Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypes.” Clin Epigenetics 10, no. 1 (July 20, 2018): 98. https://doi.org/10.1186/s13148-018-0532-x.Full Text Link to Item
-
Mitchell, John T., Thomas S. Weisner, Peter S. Jensen, Desiree W. Murray, Brooke S. G. Molina, L Eugene Arnold, Lily Hechtman, et al. “How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.” J Atten Disord 22, no. 9_suppl (July 2018): 49S-60S. https://doi.org/10.1177/1087054716685842.Full Text Link to Item
-
Dozmorov, Mikhail G., Staci D. Bilbo, Scott H. Kollins, Nancy Zucker, Elizabeth K. Do, Julia C. Schechter, Junfeng Jim Zhang, Susan K. Murphy, Cathrine Hoyo, and Bernard F. Fuemmeler. “Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning.” Brain Behav Immun 70 (May 2018): 390–97. https://doi.org/10.1016/j.bbi.2018.03.029.Full Text Link to Item
-
Sanchez, C. E., C. Barry, A. Sabhlok, K. Russell, A. Majors, S. H. Kollins, and B. F. Fuemmeler. “Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.” Obes Rev 19, no. 4 (April 2018): 464–84. https://doi.org/10.1111/obr.12643.Full Text Link to Item
-
Lee, Chien-Ti, Francis J. McClernon, Scott H. Kollins, and Bernard F. Fuemmeler. “Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.” J Pediatr Psychol 43, no. 2 (March 1, 2018): 162–71. https://doi.org/10.1093/jpepsy/jsx098.Full Text Link to Item
-
Sweitzer, Maggie M., Scott H. Kollins, Rachel V. Kozink, Matt Hallyburton, Joseph English, Merideth A. Addicott, Jason A. Oliver, and F Joseph McClernon. “ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.” Neuropsychopharmacology 43, no. 4 (March 2018): 851–58. https://doi.org/10.1038/npp.2017.248.Full Text Link to Item
-
Schechter, Julia C., Bernard F. Fuemmeler, Cathrine Hoyo, Susan K. Murphy, Junfeng Jim Zhang, and Scott H. Kollins. “Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States.” Int J Environ Res Public Health 15, no. 1 (January 6, 2018). https://doi.org/10.3390/ijerph15010083.Full Text Link to Item
-
Davis, Naomi O., Jeffrey Bower, and Scott H. Kollins. “Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.” Plos One 13, no. 1 (2018): e0189749. https://doi.org/10.1371/journal.pone.0189749.Full Text Link to Item
-
Murphy, Susan K., Nilda Itchon-Ramos, Zachary Visco, Zhiqing Huang, Carole Grenier, Rose Schrott, Kelly Acharya, et al. “Cannabinoid exposure and altered DNA methylation in rat and human sperm.” Epigenetics 13, no. 12 (2018): 1208–21. https://doi.org/10.1080/15592294.2018.1554521.Full Text Open Access Copy Link to Item
-
Mitchell, John T., Elizabeth M. McIntyre, Joseph S. English, Michelle F. Dennis, Jean C. Beckham, and Scott H. Kollins. “A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.” J Atten Disord 21, no. 13 (November 2017): 1105–20. https://doi.org/10.1177/1087054713513328.Full Text Link to Item
-
McCullough, Lauren E., Erline E. Miller, Laura E. Calderwood, Nitin Shivappa, Susan E. Steck, Michele R. Forman, Michelle A Mendez, et al. “Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?” Epigenetics 12, no. 8 (August 2017): 688–97. https://doi.org/10.1080/15592294.2017.1347241.Full Text Link to Item
-
Childress, Ann C., Scott H. Kollins, Andrew J. Cutler, Andrea Marraffino, and Carolyn R. Sikes. “Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.” J Child Adolesc Psychopharmacol 27, no. 1 (February 2017): 66–74. https://doi.org/10.1089/cap.2016.0002.Full Text Link to Item
-
Schechter, Julia C., and Scott H. Kollins. “Prenatal Smoke Exposure and ADHD: Advancing the Field.” Pediatrics 139, no. 2 (February 2017). https://doi.org/10.1542/peds.2016-3481.Full Text Link to Item
-
Lunsford-Avery, Jessica R., Andrew D. Krystal, and Scott H. Kollins. “Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.” Clin Psychol Rev 50 (December 2016): 159–74. https://doi.org/10.1016/j.cpr.2016.10.004.Full Text Link to Item
-
Schoenfelder, Erin N., and Scott H. Kollins. “Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion.” J Pediatr Psychol 41, no. 7 (August 2016): 735–40. https://doi.org/10.1093/jpepsy/jsv162.Full Text Link to Item
-
Mitchell, John T., Maggie M. Sweitzer, Angela M. Tunno, Scott H. Kollins, and F Joseph McClernon. “"I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.” Plos One 11, no. 5 (2016): e0156614. https://doi.org/10.1371/journal.pone.0156614.Full Text Open Access Copy Link to Item
-
Koblan, Kenneth S., Seth C. Hopkins, Kaushik Sarma, Fengbin Jin, Robert Goldman, Scott H. Kollins, and Antony Loebel. “Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.” Neuropsychopharmacology 40, no. 12 (November 2015): 2745–52. https://doi.org/10.1038/npp.2015.124.Full Text Link to Item
-
Vitiello, Benedetto, Deborah Lazzaretto, Kseniya Yershova, Howard Abikoff, Natalya Paykina, James T. McCracken, James J. McGough, et al. “Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.” J Am Acad Child Adolesc Psychiatry 54, no. 7 (July 2015): 550–56. https://doi.org/10.1016/j.jaac.2015.04.004.Full Text Link to Item
-
Childress, Ann C., Matthew Brams, Andrew J. Cutler, Scott H. Kollins, Jo Northcutt, Americo Padilla, and John M. Turnbow. “The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.” J Child Adolesc Psychopharmacol 25, no. 5 (June 2015): 402–14. https://doi.org/10.1089/cap.2014.0176.Full Text Link to Item
-
Mitchell, John T., Lidia Zylowska, and Scott H. Kollins. “Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.” Cogn Behav Pract 22, no. 2 (May 2015): 172–91. https://doi.org/10.1016/j.cbpra.2014.10.002.Full Text Link to Item
-
Fuemmeler, Bernard F., Cathrine Hoyo, Susan Murphy, Adriana C. Vidal, and Scott H. Kollins. “PRE-PREGNANCY OBESITY AND OFFSPRING NEUROBEHAVIORAL DEVELOPMENT.” Annals of Behavioral Medicine 49 (April 1, 2015): S252–S252.Link to Item
-
Lee, Chien-Ti, Trenette T. Clark, Scott H. Kollins, F Joseph McClernon, and Bernard F. Fuemmeler. “Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences.” Drug Alcohol Depend 148 (March 1, 2015): 180–87. https://doi.org/10.1016/j.drugalcdep.2015.01.002.Full Text Link to Item
-
Koblan, K. S., S. C. Hopkins, K. Sarma, F. Jin, R. Goldman, S. H. Kollins, and A. Loebel. “Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults.” Neuropsychopharmacology 40, no. 12 (2015): 2745–52. https://doi.org/10.1038/npp.2015.124.Full Text
-
Kollins, Scott H., Erin N. Schoenfelder, Joseph S. English, Alex Holdaway, Elizabeth Van Voorhees, Benjamin R. O’Brien, Rachel Dew, and Allan K. Chrisman. “An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.” J Subst Abuse Treat 48, no. 1 (January 2015): 96–103. https://doi.org/10.1016/j.jsat.2014.07.014.Full Text Link to Item
-
Smith, Taylor F., Arthur D. Anastopoulos, Melanie E. Garrett, Alejandro Arias-Vasquez, Barbara Franke, Robert D. Oades, Edmund Sonuga-Barke, et al. “Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.” Am J Med Genet B Neuropsychiatr Genet 165B, no. 8 (December 2014): 691–704. https://doi.org/10.1002/ajmg.b.32275.Full Text Link to Item
-
Wigal, Sharon B., Laurence L. Greenhill, Earl Nordbrock, Daniel F. Connor, Scott H. Kollins, Akwete Adjei, Ann Childress, Annamarie Stehli, and Robert J. Kupper. “A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.” J Child Adolesc Psychopharmacol 24, no. 10 (December 2014): 562–69. https://doi.org/10.1089/cap.2014.0100.Full Text Link to Item
-
Adjei, Akwete, Robert J. Kupper, Nathan S. Teuscher, Sharon Wigal, Floyd Sallee, Ann Childress, Scott H. Kollins, and Laurence Greenhill. “Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.” Clin Drug Investig 34, no. 11 (November 2014): 795–805. https://doi.org/10.1007/s40261-014-0234-x.Full Text Link to Item
-
Mitchell, John T., Michelle F. Dennis, Joseph S. English, Paul A. Dennis, Amy Brightwood, Jean C. Beckham, and Scott H. Kollins. “Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.” Subst Use Misuse 49, no. 11 (September 2014): 1446–56. https://doi.org/10.3109/10826084.2014.912229.Full Text Link to Item
-
Kollins, Scott H., and R Alison Adcock. “ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.” Prog Neuropsychopharmacol Biol Psychiatry 52 (July 3, 2014): 70–78. https://doi.org/10.1016/j.pnpbp.2014.02.002.Full Text Link to Item
-
Schoenfelder, Erin N., Stephen V. Faraone, and Scott H. Kollins. “Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.” Pediatrics 133, no. 6 (June 2014): 1070–80. https://doi.org/10.1542/peds.2014-0179.Full Text Link to Item
-
Fuemmeler, Bernard, Chien-Ti Lee, Scott Kollins, Joseph F. McClernon, and Sharnail Bazemore. “ASSOCIATION BETWEEN ATTENTION DEFICIT HYPERACTIVITY DISORDER SYMPTOMS AND ILLICIT DRUG USE IN ADD HEALTH SAMPLE.” Annals of Behavioral Medicine 47 (April 1, 2014): S46–S46.Link to Item
-
Kollins, Scott H., Joseph S. English, Nilda Itchon-Ramos, Allan K. Chrisman, Rachel Dew, Benjamin O’Brien, and F Joseph McClernon. “A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.” J Atten Disord 18, no. 2 (February 2014): 158–68. https://doi.org/10.1177/1087054712440320.Full Text Link to Item
-
Mitchell, John T., Elizabeth M. McIntyre, F Joseph McClernon, and Scott H. Kollins. “Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.” Nicotine Tob Res 16, no. 1 (January 2014): 120–25. https://doi.org/10.1093/ntr/ntt144.Full Text Link to Item
-
Mitchell, John T., Robert S. Schick, Matt Hallyburton, Michelle F. Dennis, Scott H. Kollins, Jean C. Beckham, and F Joseph McClernon. “Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study.” J Dual Diagn 10, no. 1 (2014): 19–29. https://doi.org/10.1080/15504263.2013.866841.Full Text Link to Item
-
Weisler, Richard H., Lenard A. Adler, Scott H. Kollins, David W. Goodman, Mohamed Hamdani, Bryan Dirks, and Ann C. Childress. “Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.” Neuropsychiatr Dis Treat 10 (2014): 1–12. https://doi.org/10.2147/NDT.S47087.Full Text Link to Item
-
Lee, Chien-Ti, Bernard F. Fuemmeler, F Joseph McClernon, Allison Ashley-Koch, and Scott H. Kollins. “Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.” Addict Behav 38, no. 11 (November 2013): 2683–89. https://doi.org/10.1016/j.addbeh.2013.06.013.Full Text Link to Item
-
Lee, Chien-Ti, F Joseph McClernon, Scott H. Kollins, Kevin Prybol, and Bernard F. Fuemmeler. “Childhood economic strains in predicting substance use in emerging adulthood: mediation effects of youth self-control and parenting practices.” J Pediatr Psychol 38, no. 10 (November 2013): 1130–43. https://doi.org/10.1093/jpepsy/jst056.Full Text Link to Item
-
Kollins, Scott H., Erin Schoenfelder, Joseph S. English, F Joseph McClernon, Rachel E. Dew, and Scott D. Lane. “Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).” Exp Clin Psychopharmacol 21, no. 5 (October 2013): 375–84. https://doi.org/10.1037/a0033851.Full Text Link to Item
-
Fuemmeler, Bernard, Chien-Ti Lee, Krista W. Ranby, Trenette Clark, F Joseph McClernon, Chongming Yang, and Scott H. Kollins. “Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample.” Drug Alcohol Depend 132, no. 1–2 (September 1, 2013): 301–8. https://doi.org/10.1016/j.drugalcdep.2013.02.021.Full Text Link to Item
-
Kollins, Scott H., Joseph S. English, Michelle E. Roley, Benjamin O’Brien, Justin Blair, Scott D. Lane, and F Joseph McClernon. “Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.” Psychopharmacology (Berl) 227, no. 1 (May 2013): 19–30. https://doi.org/10.1007/s00213-012-2937-0.Full Text Link to Item
-
Riddle, Mark A., Kseniya Yershova, Deborah Lazzaretto, Natalya Paykina, Gayane Yenokyan, Laurence Greenhill, Howard Abikoff, et al. “The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.” J Am Acad Child Adolesc Psychiatry 52, no. 3 (March 2013): 264-278.e2. https://doi.org/10.1016/j.jaac.2012.12.007.Full Text Link to Item
-
Wang, Gene-Jack, Nora D. Volkow, Timothy Wigal, Scott H. Kollins, Jeffrey H. Newcorn, Frank Telang, Jean Logan, et al. “Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.” Plos One 8, no. 5 (2013): e63023. https://doi.org/10.1371/journal.pone.0063023.Full Text Link to Item
-
Mitchell, J. T., C. D. Robertson, A. D. Anastopolous, R. O. Nelson-Gray, and S. H. Kollins. “Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary study.” Journal of Psychopathology and Behavioral Assessment 34, no. 4 (December 1, 2012): 510–19. https://doi.org/10.1007/s10862-012-9297-2.Full Text
-
Mitchell, John T., Elizabeth E. Van Voorhees, Michelle F. Dennis, F Joseph McClernon, Patrick S. Calhoun, Scott H. Kollins, and Jean C. Beckham. “Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder.” Nicotine Tob Res 14, no. 8 (August 2012): 986–92. https://doi.org/10.1093/ntr/ntr245.Full Text Link to Item
-
Davis, Naomi Ornstein, and Scott H. Kollins. “Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.” Neurotherapeutics 9, no. 3 (July 2012): 518–30. https://doi.org/10.1007/s13311-012-0126-9.Full Text Link to Item
-
Sallee, Floyd R., Scott H. Kollins, and Timothy L. Wigal. “Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.” J Child Adolesc Psychopharmacol 22, no. 3 (June 2012): 206–14. https://doi.org/10.1089/cap.2010.0135.Full Text Link to Item
-
Van Voorhees, Elizabeth E., John T. Mitchell, F Joseph McClernon, Jean C. Beckham, and Scott H. Kollins. “Sex, ADHD symptoms, and smoking outcomes: an integrative model.” Med Hypotheses 78, no. 5 (May 2012): 585–93. https://doi.org/10.1016/j.mehy.2012.01.034.Full Text Link to Item
-
Fuemmeler, Bernard, Chien-Ti Lee, Krista W. Ranby, Marissa Stroo, Chongming Yang, Kalin Clark, Marcella H. Boynton, Trenette Clark, Joseph McClernon, and Scott Kollins. “COMMUNITY AND INDIVIDUAL LEVEL SOCIAL CORRELATES OF SMOKING TRAJECTORIES FROM ADOLESCENCE TO ADULTHOOD.” Annals of Behavioral Medicine 43 (April 1, 2012): S210–S210.Link to Item
-
Van Voorhees, E., F. J. McClernon, B. Fuemmeler, J. English, A. Holdaway, M. Hallyburton, R. Dew, and S. Kollins. “An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorder.” Addiction Research and Theory 20, no. 1 (February 1, 2012): 72–81. https://doi.org/10.3109/16066359.2011.564692.Full Text
-
Bidwell, L Cinnamon, Melanie E. Garrett, F Joseph McClernon, Bernard F. Fuemmeler, Redford B. Williams, Allison E. Ashley-Koch, and Scott H. Kollins. “A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults.” Nicotine Tob Res 14, no. 2 (February 2012): 229–33. https://doi.org/10.1093/ntr/ntr125.Full Text Link to Item
-
Faraone, Stephen V., Thomas J. Spencer, Scott H. Kollins, Stephen J. Glatt, and David Goodman. “Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.” J Atten Disord 16, no. 2 (February 2012): 118–27. https://doi.org/10.1177/1087054711403716.Full Text Link to Item
-
Volkow, Nora D., Gene-Jack Wang, Dardo Tomasi, Scott H. Kollins, Tim L. Wigal, Jeffrey H. Newcorn, Frank W. Telang, et al. “Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.” J Neurosci 32, no. 3 (January 18, 2012): 841–49. https://doi.org/10.1523/JNEUROSCI.4461-11.2012.Full Text Link to Item
-
Ranby, Krista W., Marcella H. Boynton, Scott H. Kollins, F Joseph McClernon, Chongming Yang, and Bernard F. Fuemmeler. “Understanding the phenotypic structure of adult retrospective ADHD symptoms during childhood in the United States.” J Clin Child Adolesc Psychol 41, no. 3 (2012): 261–74. https://doi.org/10.1080/15374416.2012.654465.Full Text Link to Item
-
Volkow, N. D., G. -. J. Wang, J. H. Newcorn, S. H. Kollins, T. L. Wigal, F. Telang, J. S. Fowler, et al. “Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.” Mol Psychiatry 16, no. 11 (November 2011): 1147–54. https://doi.org/10.1038/mp.2010.97.Full Text Link to Item
-
Anastopoulos, Arthur D., Taylor F. Smith, Melanie E. Garrett, Erin Morrissey-Kane, Nicole K. Schatz, Jennifer L. Sommer, Scott H. Kollins, and Allison Ashley-Koch. “Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD.” J Atten Disord 15, no. 7 (October 2011): 583–92. https://doi.org/10.1177/1087054710370567.Full Text Link to Item
-
McClernon, F Joseph, Elizabeth E. Van Voorhees, Joe English, Matt Hallyburton, Alex Holdaway, and Scott H. Kollins. “Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.” Nicotine Tob Res 13, no. 9 (September 2011): 784–92. https://doi.org/10.1093/ntr/ntr073.Full Text Link to Item
-
Bidwell, L Cinnamon, F Joseph McClernon, and Scott H. Kollins. “Cognitive enhancers for the treatment of ADHD.” Pharmacol Biochem Behav 99, no. 2 (August 2011): 262–74. https://doi.org/10.1016/j.pbb.2011.05.002.Full Text Link to Item
-
Fuemmeler, B. F., T. Østbye, C. Yang, F. J. McClernon, and S. H. Kollins. “Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study.” Int J Obes (Lond) 35, no. 6 (June 2011): 852–62. https://doi.org/10.1038/ijo.2010.214.Full Text Open Access Copy Link to Item
-
Kollins, Scott H., Rakesh Jain, Matthew Brams, Scott Segal, Robert L. Findling, Sharon B. Wigal, and Moise Khayrallah. “Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.” Pediatrics 127, no. 6 (June 2011): e1406–13. https://doi.org/10.1542/peds.2010-1260.Full Text Link to Item
-
Kollins, Scott H., Frank A. López, Bradley D. Vince, John M. Turnbow, Kimberly Farrand, Andrew Lyne, Sharon B. Wigal, and Thomas Roth. “Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.” J Child Adolesc Psychopharmacol 21, no. 2 (April 2011): 111–20. https://doi.org/10.1089/cap.2010.0064.Full Text Link to Item
-
Kratochvil, Christopher J., Brigette S. Vaughan, Julie A. Stoner, Joan M. Daughton, Brian D. Lubberstedt, Desiree W. Murray, Allan K. Chrisman, et al. “A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.” Pediatrics 127, no. 4 (April 2011): e862–68. https://doi.org/10.1542/peds.2010-0825.Full Text Link to Item
-
Van Voorhees, Elizabeth E., Kristina K. Hardy, and Scott H. Kollins. “Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.” J Atten Disord 15, no. 3 (April 2011): 224–34. https://doi.org/10.1177/1087054709356163.Full Text Link to Item
-
Rizzi, Thais S., Alejandro Arias-Vasquez, Nanda Rommelse, Jonna Kuntsi, Richard Anney, Philip Asherson, Jan Buitelaar, et al. “The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects.” Am J Med Genet B Neuropsychiatr Genet 156, no. 2 (March 2011): 145–57. https://doi.org/10.1002/ajmg.b.31149.Full Text Link to Item
-
“Corrigendum.” Journal of the American Academy of Child &Amp; Adolescent Psychiatry 50, no. 3 (March 2011): 313–313. https://doi.org/10.1016/j.jaac.2011.01.019.Full Text
-
Bidwell, L Cinnamon, Rachel E. Dew, and Scott H. Kollins. “Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.” Curr Psychiatry Rep 13, no. 1 (February 2011): 76. https://doi.org/10.1007/s11920-010-0171-1.Full Text Link to Item
-
Jain, Rakesh, Scott Segal, Scott H. Kollins, and Moise Khayrallah. “Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.” J Am Acad Child Adolesc Psychiatry 50, no. 2 (February 2011): 171–79. https://doi.org/10.1016/j.jaac.2010.11.005.Full Text Link to Item
-
Kollins, Scott H., Sharon Youcha, Robert Lasser, and Michael E. Thase. “Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.” Innov Clin Neurosci 8, no. 2 (February 2011): 28–32.Link to Item
-
Wigal, Sharon B., Scott H. Kollins, Ann C. Childress, and Ben Adeyi. “Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.” Child Adolesc Psychiatry Ment Health 4 (December 14, 2010): 32. https://doi.org/10.1186/1753-2000-4-32.Full Text Link to Item
-
Dew, Rachel E., and Scott H. Kollins. “Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.” Expert Opin Pharmacother 11, no. 17 (December 2010): 2907–13. https://doi.org/10.1517/14656566.2010.531009.Full Text Link to Item
-
Kozink, Rachel V., Scott H. Kollins, and F Joseph McClernon. “Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control.” Neuropsychopharmacology 35, no. 13 (December 2010): 2600–2606. https://doi.org/10.1038/npp.2010.154.Full Text Link to Item
-
Cinnamon Bidwell, L., Rachel E. Dew, and Scott H. Kollins. “Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.” Curr Psychiatry Rep 12, no. 5 (October 2010): 366–73. https://doi.org/10.1007/s11920-010-0136-4.Full Text Link to Item
-
Connor, Daniel F., Robert L. Findling, Scott H. Kollins, Floyd Sallee, Frank A. López, Andrew Lyne, and Gerald Tremblay. “Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.” Cns Drugs 24, no. 9 (September 2010): 755–68. https://doi.org/10.2165/11537790-000000000-00000.Full Text Link to Item
-
Kollins, Scott H., F Joseph McClernon, and Elizabeth E. Van Voorhees. “Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD).” Exp Clin Psychopharmacol 18, no. 3 (June 2010): 221–28. https://doi.org/10.1037/a0019565.Full Text Link to Item
-
Kollins, S. “Subjective Effects of Methylphenidate,” April 1, 2010. https://doi.org/10.1093/acprof:oso/9780195165319.003.0011.Full Text
-
Markunas, Christina A., Kaia S. Quinn, Ann L. Collins, Melanie E. Garrett, Ave M. Lachiewicz, Jennifer L. Sommer, Erin Morrissey-Kane, Scott H. Kollins, Arthur D. Anastopoulos, and Allison E. Ashley-Koch. “Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families.” Psychiatr Genet 20, no. 2 (April 2010): 73–81. https://doi.org/10.1097/YPG.0b013e3283351209.Full Text Link to Item
-
Polanczyk, Guilherme, Avshalom Caspi, Renate Houts, Scott H. Kollins, Luis Augusto Rohde, and Terrie E. Moffitt. “Implications of Extending the ADHD Age-of-Onset Criterion to Age 12.” Journal of the American Academy of Child &Amp; Adolescent Psychiatry 49, no. 3 (March 2010): 210–16. https://doi.org/10.1097/00004583-201003000-00004.Full Text
-
Polanczyk, Guilherme, Avshalom Caspi, Renate Houts, Scott H. Kollins, Luis Augusto Rohde, and Terrie E. Moffitt. “Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort.” J Am Acad Child Adolesc Psychiatry 49, no. 3 (March 2010): 210–16.Link to Item
-
Faraone, Stephen V., Thomas J. Spencer, Scott H. Kollins, and Stephen J. Glatt. “Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.” J Am Acad Child Adolesc Psychiatry 49, no. 1 (January 2010): 24–32. https://doi.org/10.1097/00004583-201001000-00006.Full Text Link to Item
-
Volkow, N. D., G. J. Wang, S. H. Kollins, T. L. Wigal, J. H. Newcorn, F. Telang, J. S. Fowler, et al. “Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications (vol 302, pg 1084, 2009).” Jama Journal of the American Medical Association 302, no. 13 (October 7, 2009): 1420–1420.Link to Item
-
Volkow, Nora D., Gene-Jack Wang, Scott H. Kollins, Tim L. Wigal, Jeffrey H. Newcorn, Frank Telang, Joanna S. Fowler, et al. “Evaluating dopamine reward pathway in ADHD: clinical implications.” Jama 302, no. 10 (September 9, 2009): 1084–91. https://doi.org/10.1001/jama.2009.1308.Full Text Link to Item
-
Wigal, Sharon B., Scott H. Kollins, Ann C. Childress, Liza Squires, and Liza 311 Study Group. “A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.” Child Adolesc Psychiatry Ment Health 3, no. 1 (June 9, 2009): 17. https://doi.org/10.1186/1753-2000-3-17.Full Text Link to Item
-
Kollins, Scott H., Melanie E. Garrett, F Joseph McClernon, Ave M. Lachiewicz, Erin Morrissey-Kane, David FitzGerald, Ann L. Collins, Arthur D. Anastopoulos, and Allison E. Ashley-Koch. “Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms.” J Nerv Ment Dis 197, no. 6 (June 2009): 442–49. https://doi.org/10.1097/NMD.0b013e3181a61d9e.Full Text Link to Item
-
Fuemmeler, Bernard F., Tanya Agurs-Collins, F Joseph McClernon, Scott H. Kollins, Melanie E. Garrett, and Allison E. Ashley-Koch. “Interactions between genotype and depressive symptoms on obesity.” Behav Genet 39, no. 3 (May 2009): 296–305. https://doi.org/10.1007/s10519-009-9266-z.Full Text Link to Item
-
Kollins, Scott H., Joseph English, Rachel Robinson, Matt Hallyburton, and Allan K. Chrisman. “Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).” Psychopharmacology (Berl) 204, no. 1 (May 2009): 73–83. https://doi.org/10.1007/s00213-008-1439-6.Full Text Link to Item
-
Willoughby, Michael T., Scott H. Kollins, F Joseph McClernon, and F Joseph Family Life Investigative Group. “Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers.” Nicotine Tob Res 11, no. 3 (March 2009): 313–22. https://doi.org/10.1093/ntr/ntp001.Full Text Link to Item
-
Kollins, Scott H., F Joseph McClernon, and Jeff N. Epstein. “Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis.” Drug Alcohol Depend 100, no. 1–2 (February 1, 2009): 169–72. https://doi.org/10.1016/j.drugalcdep.2008.09.019.Full Text Link to Item
-
Kollins, S. H., A. D. Anastopoulos, A. M. Lachiewicz, D. FitzGerald, E. Morrissey-Kane, M. E. Garrett, S. L. Keatts, and A. E. Ashley-Koch. “SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.” Am J Med Genet B Neuropsychiatr Genet 147B, no. 8 (December 5, 2008): 1580–88. https://doi.org/10.1002/ajmg.b.30876.Full Text Link to Item
-
Witt, Kristine L., Michael D. Shelby, Nilda Itchon-Ramos, Melissa Faircloth, Grace E. Kissling, Allan K. Chrisman, Hima Ravi, Hemalatha Murli, Donald R. Mattison, and Scott H. Kollins. “Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.” J Am Acad Child Adolesc Psychiatry 47, no. 12 (December 2008): 1375–83. https://doi.org/10.1097/CHI.0b013e3181893620.Full Text Link to Item
-
McClernon, Francis Joseph, and Scott Haden Kollins. “ADHD and smoking: from genes to brain to behavior.” Ann N Y Acad Sci 1141 (October 2008): 131–47. https://doi.org/10.1196/annals.1441.016.Full Text Link to Item
-
Adler, Lenard A., David W. Goodman, Scott H. Kollins, Richard H. Weisler, Suma Krishnan, Yuxin Zhang, Joseph Biederman, and Joseph 303 Study Group. “Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.” J Clin Psychiatry 69, no. 9 (September 2008): 1364–73. https://doi.org/10.4088/jcp.v69n0903.Full Text Link to Item
-
Kollins, Scott H. “ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.” J Atten Disord 12, no. 2 (September 2008): 115–25. https://doi.org/10.1177/1087054707311654.Full Text Link to Item
-
Kollins, Scott H. “A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.” Curr Med Res Opin 24, no. 5 (May 2008): 1345–57. https://doi.org/10.1185/030079908x280707.Full Text Link to Item
-
McClernon, F Joseph, Scott H. Kollins, Avery M. Lutz, David P. Fitzgerald, Desiree W. Murray, Christina Redman, and Jed E. Rose. “Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.” Psychopharmacology (Berl) 197, no. 1 (March 2008): 95–105. https://doi.org/10.1007/s00213-007-1009-3.Full Text Link to Item
-
Fuemmeler, Bernard F., Tanya D. Agurs-Collins, F Joseph McClernon, Scott H. Kollins, Melanie E. Kail, Andrew W. Bergen, and Allison E. Ashley-Koch. “Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.” Obesity (Silver Spring) 16, no. 2 (February 2008): 348–55. https://doi.org/10.1038/oby.2007.65.Full Text Link to Item
-
Laforett, Doré R., Desiree W. Murray, and Scott H. Kollins. “Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.” Dev Disabil Res Rev 14, no. 4 (2008): 300–310. https://doi.org/10.1002/ddrr.36.Full Text Link to Item
-
McClernon, F Joseph, Bernard F. Fuemmeler, Scott H. Kollins, Melanie E. Kail, and Allison E. Ashley-Koch. “Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults.” Nicotine Tob Res 10, no. 1 (January 2008): 117–27. https://doi.org/10.1080/14622200701704913.Full Text Link to Item
-
Kollins, Scott H., and John S. March. “Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.” Biol Psychiatry 62, no. 9 (November 1, 2007): 951–53. https://doi.org/10.1016/j.biopsych.2007.08.009.Full Text Link to Item
-
Abikoff, Howard B., Benedetto Vitiello, Mark A. Riddle, Charles Cunningham, Laurence L. Greenhill, James M. Swanson, Shirley Z. Chuang, et al. “Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 581–92. https://doi.org/10.1089/cap.2007.0068.Full Text Link to Item
-
Ghuman, Jaswinder K., Mark A. Riddle, Benedetto Vitiello, Laurence L. Greenhill, Shirley Z. Chuang, Sharon B. Wigal, Scott H. Kollins, et al. “Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 563–80. https://doi.org/10.1089/cap.2007.0071.Full Text Link to Item
-
Hardy, Kristina K., Scott H. Kollins, Desiree W. Murray, Mark A. Riddle, Laurence Greenhill, Charles Cunningham, Howard B. Abikoff, et al. “Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 621–34. https://doi.org/10.1089/cap.2007.0073.Full Text Link to Item
-
Murray, Desiree W., Scott H. Kollins, Kristina K. Hardy, Howard B. Abikoff, James M. Swanson, Charles Cunningham, Benedetto Vitiello, et al. “Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 605–20. https://doi.org/10.1089/cap.2007.0060.Full Text Link to Item
-
Pettiford, Jasmine, Rachel V. Kozink, Avery M. Lutz, Scott H. Kollins, Jed E. Rose, and F Joseph McClernon. “Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility.” Addict Behav 32, no. 10 (October 2007): 2351–57. https://doi.org/10.1016/j.addbeh.2007.02.004.Full Text Link to Item
-
Posner, Kelly, Glenn A. Melvin, Desiree W. Murray, S Sonia Gugga, Prudence Fisher, Anne Skrobala, Charles Cunningham, et al. “Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 547–62. https://doi.org/10.1089/cap.2007.0075.Full Text Link to Item
-
Swanson, James M., Robert K. Moyzis, James J. McGough, James T. McCracken, Mark A. Riddle, Scott H. Kollins, Laurence L. Greenhill, et al. “Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 635–46. https://doi.org/10.1089/cap.2007.0076.Full Text Link to Item
-
Vitiello, Benedetto, Howard B. Abikoff, Shirley Z. Chuang, Scott H. Kollins, James T. McCracken, Mark A. Riddle, James M. Swanson, et al. “Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).” J Child Adolesc Psychopharmacol 17, no. 5 (October 2007): 593–604. https://doi.org/10.1089/cap.2007.0058.Full Text Link to Item
-
Kratochvil, Christopher J., Brigette S. Vaughan, Michelle L. Mayfield-Jorgensen, John S. March, Scott H. Kollins, Desiree W. Murray, Hima Ravi, et al. “A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.” J Child Adolesc Psychopharmacol 17, no. 2 (April 2007): 175–85. https://doi.org/10.1089/cap.2006.0143.Full Text Link to Item
-
Fuemmeler, Bernard F., Scott H. Kollins, and F Joseph McClernon. “Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.” J Pediatr Psychol 32, no. 10 (2007): 1203–13. https://doi.org/10.1093/jpepsy/jsm051.Full Text Link to Item
-
Kollins, Scott H. “Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).” Am J Addict 16 Suppl 1 (2007): 35–42. https://doi.org/10.1080/10550490601082775.Full Text Link to Item
-
Levin, Frances R. “ADHD and Sustance Abuse Update.” American Journal on Addictions 16, no. s1 (January 2007): 1–4. https://doi.org/10.1080/10550490601082726.Full Text
-
Greenhill, Laurence, Scott Kollins, Howard Abikoff, James McCracken, Mark Riddle, James Swanson, James McGough, et al. “Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.” J Am Acad Child Adolesc Psychiatry 45, no. 11 (November 2006): 1284–93. https://doi.org/10.1097/01.chi.0000235077.32661.61.Full Text Link to Item
-
Kollins, Scott, Laurence Greenhill, James Swanson, Sharon Wigal, Howard Abikoff, James McCRACKEN, Mark Riddle, et al. “Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).” J Am Acad Child Adolesc Psychiatry 45, no. 11 (November 2006): 1275–83. https://doi.org/10.1097/01.chi.0000235074.86919.dc.Full Text Link to Item
-
McGOUGH, James, James McCRACKEN, James Swanson, Mark Riddle, Scott Kollins, Laurence Greenhill, Howard Abikoff, et al. “Pharmacogenetics of methylphenidate response in preschoolers with ADHD.” J Am Acad Child Adolesc Psychiatry 45, no. 11 (November 2006): 1314–22. https://doi.org/10.1097/01.chi.0000235083.40285.08.Full Text Link to Item
-
Swanson, James, Laurence Greenhill, Tim Wigal, Scott Kollins, Annamarie Stehli, Mark Davies, Shirley Chuang, et al. “Stimulant-related reductions of growth rates in the PATS.” J Am Acad Child Adolesc Psychiatry 45, no. 11 (November 2006): 1304–13. https://doi.org/10.1097/01.chi.0000235075.25038.5a.Full Text Link to Item
-
Wigal, Tim, Laurence Greenhill, Shirley Chuang, James McGOUGH, Benedetto Vitiello, Anne Skrobala, James Swanson, et al. “Safety and tolerability of methylphenidate in preschool children with ADHD.” J Am Acad Child Adolesc Psychiatry 45, no. 11 (November 2006): 1294–1303. https://doi.org/10.1097/01.chi.0000235082.63156.27.Full Text Link to Item
-
Epstein, Jeffery N., and Scott H. Kollins. “Psychometric properties of an adult ADHD diagnostic interview.” J Atten Disord 9, no. 3 (February 2006): 504–14. https://doi.org/10.1177/1087054705283575.Full Text Link to Item
-
Kollins, S. H., and L. Greenhill. “Evidence base for the use of stimulant medication in preschool children with ADHD.” Infants and Young Children 19, no. 2 (January 1, 2006): 132–41. https://doi.org/10.1097/00001163-200604000-00006.Full Text
-
Preston, R Julian, Scott H. Kollins, James M. Swanson, Laurence L. Greenhill, Tim Wigal, Glen R. Elliott, and Benedetto Vitiello. “Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.” Cancer Lett 230, no. 2 (December 18, 2005): 292–94. https://doi.org/10.1016/j.canlet.2005.05.038.Full Text Link to Item
-
Kollins, Scott H., F Joseph McClernon, and Bernard F. Fuemmeler. “Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.” Arch Gen Psychiatry 62, no. 10 (October 2005): 1142–47. https://doi.org/10.1001/archpsyc.62.10.1142.Full Text Link to Item
-
MacDonald Fredericks, Emily, and Scott H. Kollins. “A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder.” J Child Adolesc Psychopharmacol 15, no. 5 (October 2005): 729–41. https://doi.org/10.1089/cap.2005.15.729.Full Text Link to Item
-
Wigal, Sharon B., James J. McGough, James T. McCracken, Joseph Biederman, Thomas J. Spencer, Kelly L. Posner, Tim L. Wigal, et al. “A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.” J Atten Disord 9, no. 1 (August 2005): 275–89. https://doi.org/10.1177/1087054705281121.Full Text Link to Item
-
Fredericks, Emily MacDonald, and Scott H. Kollins. “Assessing methylphenidate preference in ADHD patients using a choice procedure.” Psychopharmacology (Berl) 175, no. 4 (October 2004): 391–98. https://doi.org/10.1007/s00213-004-1838-2.Full Text Link to Item
-
Swanson, James M., Sharon B. Wigal, Tim Wigal, Edmund Sonuga-Barke, Laurence L. Greenhill, Joseph Biederman, Scott Kollins, et al. “A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).” Pediatrics 113, no. 3 Pt 1 (March 2004): e206–16. https://doi.org/10.1542/peds.113.3.e206.Full Text Link to Item
-
Kollins, Scott H. “Delay discounting is associated with substance use in college students.” Addict Behav 28, no. 6 (August 2003): 1167–73. https://doi.org/10.1016/s0306-4603(02)00220-4.Full Text Link to Item
-
Kollins, Scott H. “Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.” J Clin Psychiatry 64 Suppl 11 (2003): 14–18.Link to Item
-
Kollins, Scott H., and Craig R. Rush. “Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans.” Biol Psychiatry 51, no. 2 (January 15, 2002): 143–50. https://doi.org/10.1016/s0006-3223(01)01288-4.Full Text Link to Item
-
Kollins, S. H., E. K. MacDonald, and C. R. Rush. “Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.” Pharmacol Biochem Behav 68, no. 3 (March 2001): 611–27. https://doi.org/10.1016/s0091-3057(01)00464-6.Full Text Link to Item
-
Kollins, S. H., R. A. Barkley, and G. J. DuPaul. “Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD).” Focus on Exceptional Children 33, no. 5 (January 1, 2001). https://doi.org/10.17161/fec.v33i5.6779.Full Text
-
Kollins, S. H., R. A. Barkley, and G. J. DuPaul. “Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD).” Focus on Exceptional Children 33, no. 5 (January 1, 2001): X–24.
-
Kollins, S. H., R. A. Barkley, and G. J. DuPaul. “Use and management of medications for children diagnosed with attention deficit hyperactivity disorder (ADHD).” Focus on Exceptional Children 33, no. 5 (January 1, 2001): 1-+.Link to Item
-
Critchfield, T. S., and S. H. Kollins. “Temporal discounting: basic research and the analysis of socially important behavior.” J Appl Behav Anal 34, no. 1 (2001): 101–22. https://doi.org/10.1901/jaba.2001.34-101.Full Text Link to Item
-
Critchfield, T. S., M. C. Newland, and S. H. Kollins. “The good, the bad, and the aggregate.” Behav Anal 23, no. 1 (2000): 107–15. https://doi.org/10.1007/BF03392005.Full Text Link to Item
-
Murray, L. K., and S. H. Kollins. “Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.” J Appl Behav Anal 33, no. 4 (2000): 573–91. https://doi.org/10.1901/jaba.2000.33-573.Full Text Link to Item
-
Kollins, S. H., and C. R. Rush. “Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.” Pharmacol Biochem Behav 64, no. 2 (October 1999): 319–26. https://doi.org/10.1016/s0091-3057(99)00084-2.Full Text Link to Item
-
Daleiden, E. L., B. F. Chorpita, S. H. Kollins, and R. S. Drabman. “Factors affecting the reliability of clinical judgments about the function of children's school-refusal behavior.” J Clin Child Psychol 28, no. 3 (September 1999): 396–406. https://doi.org/10.1207/S15374424jccp280312.Full Text Link to Item
-
Forsyth, J. P., S. Kollins, A. Palav, K. Duff, and S. Maher. “Has behavior therapy drifted from its experimental roots? A survey of publication trends in mainstream behavioral journals.” J Behav Ther Exp Psychiatry 30, no. 3 (September 1999): 205–20. https://doi.org/10.1016/s0005-7916(99)00020-8.Full Text Link to Item
-
Kollins, S. H., M. C. Newland, and T. S. Critchfield. “Quantitative integration of single-subject studies: Methods and misinterpretations.” Behav Anal 22, no. 2 (1999): 149–57. https://doi.org/10.1007/BF03391992.Full Text Link to Item
-
Phillips, E. L., S. Kollins, and D. Edgerly. “Behavioural assessment of children and adolescents.” Indian J Pediatr 66, no. 3 (1999): 389–99. https://doi.org/10.1007/BF02845532.Full Text Link to Item
-
Kollins, S. H., C. R. Rush, P. J. Pazzaglia, and J. A. Ali. “Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.” Exp Clin Psychopharmacol 6, no. 4 (November 1998): 367–74. https://doi.org/10.1037//1064-1297.6.4.367.Full Text Link to Item
-
Kollins, Scott H., Steven K. Shapiro, M. C. Newland, and Ann Abramowitz. “Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).” Exp Clin Psychopharmacol 6, no. 4 (November 1998): 375–89. https://doi.org/10.1037/1064-1297.6.4.375.Full Text Link to Item
-
Rush, C. R., S. H. Kollins, and P. J. Pazzaglia. “Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.” Exp Clin Psychopharmacol 6, no. 1 (February 1998): 32–44. https://doi.org/10.1037//1064-1297.6.1.32.Full Text Link to Item
-
Kollins, Scott H., M Christopher Newland, and Thomas S. Critchfield. “Erratum to: Human sensitivity to reinforcement in operant choice: How much do consequences matter?” Psychonomic Bulletin &Amp; Review 4, no. 3 (September 1997): 431–431. https://doi.org/10.3758/bf03210806.Full Text
-
Kollins, S. H., M. C. Newland, and T. S. Critchfield. “Human sensitivity to reinforcement in operant choice: How much do consequences matter?” Psychon Bull Rev 4, no. 2 (June 1997): 208–20. https://doi.org/10.3758/BF03209395.Full Text Link to Item
-
Kollins, S. H., S. D. Lane, and S. K. Shapiro. “Experimental analysis of childhood psychopathology: A laboratory matching analysis of the behavior of children diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD).” Psychological Record 47, no. 1 (January 1, 1997): 25–44. https://doi.org/10.1007/BF03395211.Full Text
-
-
Book Sections
-
Bidopia, T., M. M. Engelhard, S. H. Kollins, and J. R. Lunsford-Avery. “Screen media technology and ADHD in children and adolescents: Potential perils and emerging opportunities.” In Encyclopedia of Child and Adolescent Health, First Edition, 3:260–74, 2023. https://doi.org/10.1016/B978-0-12-818872-9.00126-6.Full Text
-
Lusby, C. M., and S. H. Kollins. “Attention-deficit/hyperactivity disorder and college students.” In Principles and Practice of College Health, 77–85, 2020. https://doi.org/10.1007/978-3-030-56309-7_5.Full Text
-
Kollins, S. H., and F. J. McClernon. “ADHD and smoking.” In Attention-Deficit Hyperactivity Disorder in Adults and Children, 327–42, 2015. https://doi.org/10.1017/CBO9781139035491.027.Full Text
-
Kollins, S. H., J. N. Epstein, and C. Keith Conners. “Corners' rating scales-revised.” In The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Volume 2: Instruments for Children and Adolescents, 215–33, 2014.
-
Mitchell, J. T., and S. H. Kollins. “ADHD in adolescence.” In Adolescent Health Psychology, edited by W. O’Donohue, L. Benuto, and L. Tolle, 423–45. Springer, 2013.
-
Mitchell, J. T., and S. H. Kollins. “Attention-deficit/hyperactivity disorder in adolescence.” In Handbook of Adolescent Health Psychology, 423–45, 2013. https://doi.org/10.1007/978-1-4614-6633-8_27.Full Text
-
Kollins, S. H. “Abuse potential of stimulant drugs used to treat ADHD.” In ADHD in Adults: Characterization, Diagnosis, and Treatment, 230–39, 2011. https://doi.org/10.1017/CBO9780511780752.020.Full Text
-
-
Conference Papers
-
Glasgow, Trevin E., Elizabeth L. Adams, Albert Ksinan, D Jeremy Barsell, Jessica Lunsford-Avery, Shanshan Chen, Scott Kollins, et al. “Sleep onset, duration, or regularity: which matters most for child adiposity outcomes?” In Int J Obes (Lond), 46:1502–9, 2022. https://doi.org/10.1038/s41366-022-01140-0.Full Text Link to Item
-
Ann Catherine Childress, Scott H., Scott H. Kollins, Andrew J. Cutler, Andrea Marraffino, and Carolyn Sikes. “5.10 EFFICACY AND SAFETY OF AN EXTENDED-RELEASE, ORALLY DISINTEGRATING METHYLPHENIDATE TABLET IN CHILDREN 6-12 YEARS OF AGE BASED ON ADHD RATING SCALE-IV SCORE AT BASELINE.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 59:S152–S152. Elsevier BV, 2020. https://doi.org/10.1016/j.jaac.2020.08.070.Full Text
-
Childress, Ann Catherine, Jacqueline Lutz, and Scott H. Kollins. “5.26 STARS-ADJUNCT: AKL-T01, A DIGITAL TREATMENT FOR PEDIATRIC ADHD AS AN ADJUNCT TO STIMULANT MEDICATION: RESPONSE RATES WITH REPEAT ADMINISTRATION.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 59:S157–S157. Elsevier BV, 2020. https://doi.org/10.1016/j.jaac.2020.08.087.Full Text
-
Davis, Naomi, Jacqueline Lutz, and Scott H. Kollins. “5.27 STARS-ADJUNCT: AKL-T01, A HOME-BASED DIGITAL INTERVENTION AS AN ADJUNCT TO STIMULANT MEDICATION FOR PEDIATRIC ADHD: ACADEMIC PERFORMANCE AND RELATION TO OBJECTIVE MEASURES OF ATTENTION.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 59:S157–58. Elsevier BV, 2020. https://doi.org/10.1016/j.jaac.2020.08.088.Full Text
-
Epstein, Jeffery N., Jacqueline Lutz, Denton DeLoss, and Scott H. Kollins. “5.13 EXPLORING ENGAGEMENT AS A FACTOR FOR EFFICACY WITH AKL-T01, A HOME-BASED DIGITAL THERAPEUTIC.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 59:S153–S153. Elsevier BV, 2020. https://doi.org/10.1016/j.jaac.2020.08.074.Full Text
-
Kollins, Scott H., Andrew Heusser, and Jacqueline Lutz. “5.25 STARS-ADJUNCT: A HOME-BASED, DIGITAL TREATMENT FOR PEDIATRIC ADHD AS ADJUNCT TO STIMULANT MEDICATION: INSIGHTS ON REPEAT ADMINISTRATION AND THE STABILITY OF EFFECTS.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 59:S157–S157. Elsevier BV, 2020. https://doi.org/10.1016/j.jaac.2020.08.086.Full Text
-
Lunsford-Avery, J. R., A. D. Krystal, M. A. Carskadon, and S. H. Kollins. “SLEEP ASSOCIATED WITH EXECUTIVE FUNCTIONING AMONG ADOLESCENTS ACROSS THE ADHD CONTINUUM.” In Sleep, 43:A373–A373, 2020.Link to Item
-
Kollins, Scott H. “Duration of Effect of a Novel, Home-Based, Digital Treatment for Pediatric ADHD.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 58:S296–S296. Elsevier BV, 2019. https://doi.org/10.1016/j.jaac.2019.09.008.Full Text
-
Kollins, Scott H. “37.4 COMPUTER-BASED AND PARENT-REPORTED ASSESSMENT OF EXECUTIVE FUNCTIONING: METHOD VARIANCE AND IMPLICATIONS FOR INTERPRETING FINDINGS FROM ADHD EFFICACY TRIALS.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 58:S356–S356. Elsevier BV, 2019. https://doi.org/10.1016/j.jaac.2019.07.925.Full Text
-
Chen, S., R. Perera, M. M. Engelhard, J. R. Lunsford-Avery, S. H. Kollins, and B. F. Fuemmeler. “A generic algorithm for sleep-wake cycle detection using unlabeled actigraphy data.” In 2019 Ieee Embs International Conference on Biomedical and Health Informatics, Bhi 2019 Proceedings, 2019. https://doi.org/10.1109/BHI.2019.8834568.Full Text
-
Childress, Ann Catherine, Scott H. Kollins, Akwete Lex Adjei, Peter Haddock, Henry C. Foehl, Gregory Mattingly, and Jeffrey H. Newcorn. “4.15 The Efficacy and Safety of Methylphenidate Hydrochloride (HCL) Extended-Release in Preschool Aged Children With ADHD.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 57:S209–S209. Elsevier BV, 2018. https://doi.org/10.1016/j.jaac.2018.09.241.Full Text
-
Childress, Ann Catherine, Scott H. Kollins, James Wu, and Brigitte Robertson. “2.22 Lisdexamfetamine Dimesylate for Preschool Children With ADHD.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 57:S165–66. Elsevier BV, 2018. https://doi.org/10.1016/j.jaac.2018.09.110.Full Text
-
Kollins, Scott H., Jeffrey Bower, Robert L. Findling, Richard Keefe, Jeffrey Epstein, Andrew J. Cutler, Roseann White, Laura Aberle, Denton DeLoss, and Stephen V. Faraone. “2.40 A Multicenter, Randomized, Active-Control Registration Trial of Software Treatment for Actively Reducing Severity of ADHD (Stars-Adhd) to Assess the Efficacy and Safety of a Novel, Home-Based, Digital Treatment for Pediatric ADHD.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 57:S172–S172. Elsevier BV, 2018. https://doi.org/10.1016/j.jaac.2018.09.128.Full Text
-
Lunsford-Avery, J. R., S. H. Kollins, and A. D. Krystal. “0762 Sleeping at Home: Feasibility and Tolerability of Ambulatory Polysomnography for Use with Adolescents with Attention-Deficit/Hyperactivity Disorder.” In Sleep, 41:A283–84. Oxford University Press (OUP), 2018. https://doi.org/10.1093/sleep/zsy061.761.Full Text
-
Kollins, Scott, Ed Levin, Tom Price, and Susan Murphy. “Delta-9-Tetrahydrocannabinol Exposure Alters Sperm Methylation Profiles: Concurrent Results From Humans and Rats.” In Neuropsychopharmacology, 42:S642–43. NATURE PUBLISHING GROUP, 2017.Link to Item
-
Mitchell, John T., Andrea L. Howard, James M. Swanson, Traci M. Kennedy, Annamarie Stehli, Katherine A. Belendiuk, Scott H. Kollins, and Brooke S. G. Molina. “21.2 Substance Use Among Children With and Without Attention-Deficit/Hyperactivity Disorder Followed Prospectively Into Early Adulthood in the MTA.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 56:S334–35. Elsevier BV, 2017. https://doi.org/10.1016/j.jaac.2017.07.700.Full Text
-
Murphy, S. K., R. Schrott, Z. Visco, Z. Huang, C. Grenier, J. Mitchell, J. Schechter, et al. “Environment and Gametic Epigenetic Reprogramming.” In Environmental and Molecular Mutagenesis, 58:S28–S28. WILEY, 2017.Link to Item
-
Sweitzer, Maggie, Scott Kollins, Rachel Kozink, Matt Hallyburton, Joseph English, Merideth Addicott, Jason Oliver, and Francis McClernon. “ADHD, Smoking Withdrawal, and Resting State Functional Connectivity: Results of a fMRI Study With Methylphenidate Challenge.” In Neuropsychopharmacology, 41:S614–15. NATURE PUBLISHING GROUP, 2016.Link to Item
-
Kollins, Scott H., Andrew J. Cutler, Sohail Khattak, Margaret D. Weiss, Graeme Donnelly, and Joseph L. Reiz. “6.41 A SIX-MONTH OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF PRC-063 IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 55:S217–S217. Elsevier BV, 2016. https://doi.org/10.1016/j.jaac.2016.09.361.Full Text
-
Kollins, Scott H., Andrew J. Cutler, Sohail Khattak, Margaret D. Weiss, Graeme Donnelly, and Joseph L. Reiz. “6.42 A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY MEASURING THE EFFICACY AND SAFETY OF A NOVEL, EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE (PRC-063) IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER.” In Journal of the American Academy of Child &Amp; Adolescent Psychiatry, 55:S217–18. Elsevier BV, 2016. https://doi.org/10.1016/j.jaac.2016.09.362.Full Text
-
Kollins, Scott, Francis McClernon, Joseph English, Denny Hood, and Kenneth Perkins. “Initial Response to Intranasal Nicotine Young Adults With and Without Attention Deficit Hyperactivity Disorder.” In Neuropsychopharmacology, 41:S452–53, 2016.Link to Item
-
McDonnell, M., S. Wigal, A. Childress, S. Kollins, N. DeSousa, M. Komolova, and F. Sallee. “A Treatment Optimization Study of HLD200 in Children with Attention-Deficit/Hyperactivity Disorder.” In Annals of Neurology, 80:S391–S391, 2016.Link to Item
-
Koblan, Kenneth, Seth Hopkins, Kaushik Sarma, Fengbin Jin, Robert Goldman, Antony Loebel, and Scott Kollins. “Dasotraline as a Novel DAT/NET Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-concept Trial in Adults.” In Neuropsychopharmacology, 39:S347–S347. NATURE PUBLISHING GROUP, 2014.Link to Item
-
McClernon, Francis J., John T. Mitchell, Robert S. Schick, Rebecca L. Bayham, Michelle E. Dennis, Scott H. Kollins, and Jean C. Beckham. “COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDY.” In Annals of Behavioral Medicine, 45:S93–S93. SPRINGER, 2013.Link to Item
-
Bidwell, L Cinnamon, Melanie E. Garrett, F Joseph McClernon, Bernard F. Fuemmeler, Redford B. Williams, Allison E. Ashley-Koch, and Scott H. Kollins. “Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sample.” In Behavior Genetics, 41:893–893. SPRINGER, 2011.Link to Item
-
Volkow, Nora, Gene-Jack Wang, Dardo Tomasi, Scott Kollins, Tim Wigal, Jeffrey Newcorn, Frank Telang, Joanna Fowler, Jean Logan, and James Swanson. “Methylphenidate induced dopamine increases in striatum and temporal and frontal cortices predicts response to treatment in ADHD.” In Journal of Nuclear Medicine, Vol. 52, 2011.Link to Item
-
Connor, Daniel, Scott Kollins, Robert Findling, Frank Lopez, Floyd Sallee, Andrew Lyne, and Gerald Tremblay. “Effects of Guanfacine Extended Release in Children Aged 6 to 12 Years with Oppositional Symptoms and a Diagnosis of Attention-Deficit/Hyperactivity Disorder.” In Biological Psychiatry, 67:217S-217S, 2010.Link to Item
-
Turnbow, John, Scott Kollins, Frank Lopez, Andrew Lyne, Sharon Youcha, and Jonathan Rubin. “Response to Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).” In Biological Psychiatry, 67:218S-218S, 2010.Link to Item
-
Volkow, Nora D., Gene-Jack Wang, Scott Kollins, Tim Wigal, Jeffrey Newcorn, Frank Telang, Joanna Fowler, and James Swanson. “Dopamine's Role in ADHD Symptoms: Beyond an Attention Deficit.” In Biological Psychiatry, 67:96S-96S, 2010.Link to Item
-
Wang, Gene-Jack, Nora Volkow, Timothy Wigal, Scott Kollins, Jeffrey Newcorn, Frank Telang, Jean Logan, Christopher Wong, Joanna Fowler, and James Swanson. “Tolerance to the dopaminergic effects of methylphenidate in adults with ADHD after one-year treatment with methylphenidate.” In Journal of Nuclear Medicine, Vol. 51, 2010.Link to Item
-
Wang, G. -. J., N. Volkow, T. Wigal, S. Kollins, J. Newcorn, F. Telang, J. Logan, C. Wong, J. S. Fowler, and J. M. Swanson. “Chronic treatment with methylphenidate increases dopamine transporter density in patients with attention deficit hyperactive disorder.” In Journal of Nuclear Medicine, Vol. 50, 2009.Link to Item
-
Witt, K. L., M. D. Shelby, N. Itchon-Ramos, M. Faircloth, G. E. Kissling, A. K. Chrisman, H. Ravi, H. Murli, D. R. Mattison, and S. H. Kollins. “Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugs.” In Environmental and Molecular Mutagenesis, 49:528–528. WILEY-BLACKWELL, 2008.Link to Item
-
Goodman, D., L. Adler, S. H. Kollins, R. Weisler, S. Krishnan, Y. Zhang, and J. Biederman. “Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.” In International Journal of Neuropsychopharmacology, 11:292–93. CAMBRIDGE UNIV PRESS, 2008.Link to Item
-
Kollins, Scott H., Timothy Wigal, Bradley Vince, Andrew Lyne, and Kimberly Farrand. “Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effects.” In Biological Psychiatry, 63:246S-246S. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Kollins, Scott, Jeff Epstein, Simon Tonev, Arthur Anastopoulos, Ave Lachiewicz, David Fitzgerald, Erin Kane, et al. “Genetic associations with reaction time variability in AD/HD.” In American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 141B:771–72. WILEY-LISS, 2006.Link to Item
-
Schug, M. D., A. Anastopoulos, S. Kollins, L. Hennis, S. Nelson, L. Mehltretter, J. Gilbert, M. Cuccaro, and A. Ashley-Koch. “The genetics of AD/HD: Subtyping, comorbidity and developmental considerations.” In American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 130B:103–103. WILEY-LISS, 2004.Link to Item
-
-
Datasets
-
Schrott, Rose, Douglas Raburn, Scott Kollins, Edward Levin, David Corcoran, Marie-Helene Boudreau, Zhiqing Huang, et al. “Data from: Cannabinoid exposure and altered DNA methylation in rat and human sperm,” August 25, 2020. https://doi.org/10.7924/r4v122j79.Data Access
-
-
- Teaching & Mentoring
-
Advising & Mentoring
- I have been actively involved in clinical research mentorship activities throughout my career. I currently have 5 mentees with funded research programs by NIH and the Brain and Behavior Foundation and 2 additional post-docs and junior faculty have applied for funding. I stay actively involved in mentorship activities through the Duke School of Medicine Office of Faculty Development and the Duke Clinical Research Institute (DCRI). My mentorship of junior clinical researchers has been facilitated in large part over the past 7 years by the support of the National Institute on Drug Abuse (K24DA023464).
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.